Organogenesis Holdings Inc. (ORGO): Gross Profit

Annual figures by period end, from SEC filings.

$366.30M
Year ended 2024-12-31
+1.2%
3-year compound annual growth
+14.6%
5-year compound annual growth
2016-12-31: $90.53M2017-12-31: $137.29M2018-12-31: $124.64M2019-12-31: $185.03M2020-12-31: $250.98M2021-12-31: $353.16M2022-12-31: $345.87M2023-12-31: $326.66M2024-12-31: $366.30M$366.30M
2016-12-31 Gross Profit (USD) 2024-12-31
Period endedGross ProfitChange YoYSource filing
2024-12-31$366.30M+12.1%2025-02-27, From 2024-01-01
2023-12-31$326.66M-5.6%2025-02-27, From 2023-01-01
2022-12-31$345.87M-2.1%2025-02-27, From 2022-01-01
2021-12-31$353.16M+40.7%2024-02-29, From 2021-01-01
2020-12-31$250.98M+35.6%2023-03-01, From 2020-01-01
2019-12-31$185.03M+48.5%2022-03-01, From 2019-01-01
2018-12-31$124.64M-9.2%2021-03-16, From 2018-01-01
2017-12-31$137.29M+51.6%2020-03-09, From 2017-01-01
2016-12-31$90.53Mn/a2019-03-18, From 2016-01-01